BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang XM, Zhong X, Du YJ, Guo YY, Pan TR. Effects of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients. World J Diabetes 2023; 14(8): 1280-1288 [PMID: 37664475 DOI: 10.4239/wjd.v14.i8.1280]
URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1280.htm
Number Citing Articles
1
Tirzepatide a novel anti diabetic molecule unfold dual actionDiscover Public Health 2024; 21(1) doi: 10.1186/s12982-024-00200-2
2
Е. L. Nasonov, Т. S. Panevin, Е. А. Troshina. Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatologyRheumatology Science and Practice 2024; 62(2): 135 doi: 10.47360/1995-4484-2024-135-144